Oxford, United Kingdom · Founded 2001 · Privately Held (backing)
Developer of an artificial intelligence-driven drug discovery platform designed to support the identification and development of new therapeutic candidates. Oxford Drug Design is based in Oxford, United Kingdom and was founded in 2001. Its last reported valuation was $12.7 million in Dec 2025. It has raised $16.5 million.
Last reported valuation
$12.7M
Oct 2026
Priced at
—
Total raised
$16.5M
Last round
—
Cap table — not yet on record
Oxford Drug Design's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Oxford Drug Design with a free account
·The complete investor list: 22 names
·Watch Oxford Drug Design: the Monday email on marks, rounds and moves
